Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation.

MLA

Ng, Khai P., et al. “Atrial Fibrillation in CKD: Balancing the Risks and Benefits of Anticoagulation.” American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation, vol. 62, no. 3, Sept. 2013, pp. 615–32. EBSCOhost, https://doi.org/10.1053/j.ajkd.2013.02.381.

APA

Ng, K. P., Edwards, N. C., Lip, G. Y. H., Townend, J. N., & Ferro, C. J. (2013). Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation. American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation, 62(3), 615–632. https://doi.org/10.1053/j.ajkd.2013.02.381

Chicago

Ng, Khai P, Nicola C Edwards, Gregory Y H Lip, Jonathan N Townend, and Charles J Ferro. 2013. “Atrial Fibrillation in CKD: Balancing the Risks and Benefits of Anticoagulation.” American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation 62 (3): 615–32. doi:10.1053/j.ajkd.2013.02.381.